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Association between thyroid 
cysts and hypertension 
by atherosclerosis status: 
a cross‑sectional study
Yuji Shimizu1,2*, Shin‑Ya Kawashiri1, Yuko Noguchi1, Yasuhiro Nagata3, Takahiro Maeda1,4 & 
Naomi Hayashida5
Our recent studies indicate that thyroid cysts have clinical implications. Thyroid cysts could have 
a positive effect on the supply of thyroid hormones. Both hyperthyroidism and hypothyroidism 
cause hypertension. Hypothyroidism, but not hyperthyroidism, is a risk factor for atherosclerosis. 
Therefore, thyroid cysts could be associated with hypertension, and atherosclerosis might influence 
the association between thyroid cysts and hypertension. To evaluate the clinical significance of thyroid 
cysts, a cross‑sectional study was conducted with 1801 Japanese aged 40–74 years. Thyroid cysts were 
significantly positively associated with hypertension in participants without atherosclerosis. However, 
there was a significant inverse association in those with atherosclerosis. The potential confounding 
factor adjusted odd ratios and 95% confidence intervals (95% CIs) were 1.49 (95% CI 1.17–1.90) for 
participants without atherosclerosis and 0.49 (95% CI 0.24–0.98) for those with atherosclerosis. The 
present study demonstrates that thyroid cysts have clinical implications because thyroid cysts support 
thyroid hormone activity. Our findings provide sufficient evidence to develop a risk assessment for 
hypertension for the general population, even though further research is required.
Although thyroid cysts are generally regarded to be clinically insignificant, our recent studies indicate that thyroid 
cysts might have clinical effects on the activity of thyroid  hormones1–3. Anti-thyroid peroxidase antibody (TPO-
Ab) is a known autoimmune antibody. The absence of thyroid cysts has been shown to be positively associated 
with TPO-Ab1. Thyroid disorder can lead to  hypertension4. Therefore, among participants with normal thyroid 
function, participants with TPO-Ab (+) might have latent thyroid damage. TPO-Ab (+) status has been shown 
to be associated with hypertension-related latent thyroid damage. TPO-Ab (+) status is positively associated with 
subclinical hypothyroidism and hypertension, but not with subclinical hypothyroidism without  hypertension2.
In addition, this previous study also showed that the presence of thyroid cysts might influence the association 
between subclinical hypothyroidism and hypertension; subclinical hypothyroidism is positively associated with 
hypertension among participants without thyroid cysts but not participants with thyroid  cysts2. These associa-
tions could indicate that thyroid cysts can prevent hypothyroidism-related hypertension. Therefore, thyroid cysts 
could help maintain the latent function of thyroid hormone activity.
Both hyperthyroidism and hypothyroidism can lead to  hypertension4. Therefore, the presence of thyroid 
cysts could be associated with hypertension by enhancing the effect of hyperthyroidism and reducing the effect 
of hypothyroidism in the general population.
In addition, lower levels of the thyroid hormone triiodothyronine (T3) were demonstrated to be associated 
with the progression of atherosclerosis in coronary  arteries5. Therefore, an analysis of participants with ath-
erosclerosis might strengthen the influence of decreased thyroid hormone activity. Meanwhile, an analysis of 
participants without atherosclerosis might strengthen the influence of higher activity of thyroid hormones [T3 
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and thyroxine (T4)]. Since the normal range of TPO-Ab titers is associated with atherosclerosis among euthyroid 
 individuals6, latent damage of the thyroid might also influence the progression of atherosclerosis.
Therefore, the clinical characteristics of thyroid cysts might influence atherosclerosis and hypertension. To 
evaluate the clinical significance of thyroid cysts, we conducted a cross-sectional study of 1722 Japanese aged 
40–74 years who participated in an annual health check-up in 2014.
Materials and methods
Study population. The methods related to the present risk surveys, including thyroid function, have been 
described  elsewhere1–3. Researchers ensured that prospective participants understood the objectives of the study. 
Written informed consent was obtained. This study was approved by the ethics committee of the Nagasaki Uni-
versity Graduate School of Biomedical Sciences (project registration number 14051404).
All of the study procedures involving human participants were performed in accordance with the ethical 
standards of the institution research committee and the 1964 Helsinki Declaration and later amendments for 
comparable ethical standards.
Study participants consisted of 1883 Japanese individuals aged 40–74 years from the town of Saza in western 
Japan. They underwent an annual medical check-up in 2014, as recommended by the Japanese government.
To avoid the influence of thyroid diseases, we excluded all participants with a history of thyroid disease 
(n = 60) and those without data on thyroid function. We excluded those with missing values for thyroid stimulat-
ing hormone (TSH), free T3, or free T4 (n = 17). We also excluded participants without data on body mass index 
(BMI) (n = 1), blood pressure (n = 1), smoking status (n = 2), and drinking status (n = 1).
Finally, 1801 participants with a mean age of 60.5 years [standard deviation (SD): 9.2; range 40–74] were 
analyzed in the present study.
Data collection and laboratory measurements. Trained interviewers obtained information about 
clinical characteristics. Body weight and height were measured with an automatic body composition ana-
lyzer (BF-220; Tanita, Tokyo, Japan). Based on those measurements, BMI (kg/m2) was calculated. Resting sys-
tolic blood pressure (SBP) and diastolic blood pressure (DBP) were recorded. Hypertension was defined as 
SBP ≥ 140 mmHg, DBP ≥ 90 mmHg, or use of anti-hypertensive medication. Systolic hypertension was defined 
as SBP ≥ 140 mmHg while diastolic hypertension was defined as DBP ≥ 90 mmHg.
Fasting blood samples were collected. TSH, free T3, and free T4 were measured using the standard procedure 
at the LSI Medience Corporation (Tokyo, Japan). Hemoglobin A1c (HbA1c), triglycerides (TG), and high-density 
lipoprotein-cholesterol (HDLc) were measured using the standard procedure at SRL, Inc. (Tokyo, Japan).
Detection of thyroid cysts and evaluation of carotid intima-media thickness (CIMT) were performed by 
experienced technicians using a LOGIQ Book XP with a 10-MHz transducer (GE Healthcare, Milwaukee, WI, 
USA). In this study, thyroid cyst was defined as a structure with a maximum diameter of ≥ 2.0 mm containing 
no solid components. Maximum CIMT values for the left and right common carotid arteries were calculated 
with semi-automated digital edge-detection software (Intimascope; MediaCross, Tokyo, Japan) using a protocol 
that has been described in detail  elsewhere7. Peak right and left CIMT measurements excluding plaques were 
calculated. The higher CIMT value was then used for analysis. Since a previous study reported normal CIMT 
as < 1.1  mm8, we defined atherosclerosis as CIMT ≥ 1.1 mm.
Statistical analysis. Male gender, anti-hypertensive medication use, daily drinking, and current smoker 
status were presented as percentages. Other characteristics of the study population were expressed as means ± SD 
by thyroid cyst status. Since TSH had a skewed distribution, the characteristics of the study population were 
expressed as medians (interquartile range), followed by logarithmic transformation. Differences by thyroid cyst 
status were calculated.
Logistic regression was used to calculate odds ratios (ORs) and 95% confidence intervals (CIs) of hypertension 
and atherosclerosis in relation to free T3. Logistic regression was also used to calculate ORs and 95% CIs to iden-
tify possible associations between hypertension, systolic hypertension, diastolic hypertension, and thyroid cysts.
In addition, study participants were stratified by atherosclerosis status. Three adjustment models were used. 
The first model adjusted for sex and age only (Model 1). The second model (Model 2) adjusted for variables in 
Model 1 plus potential confounding factors that are well known cardiovascular risk factors, such as BMI (kg/
m2), smoking status (never, former, and current), drinking status (non, often, and daily), HbA1c (%), TG (mg/
dL), and HDLc (mg/dL). The third model (Model 3) adjusted for variables in Model 2 plus variables directly 
associated with thyroid function: TSH (μIU/mL), free T3 (pg/mL), and free T4 (ng/mL).
All statistical analyses were performed with SAS for Windows, version 9.4 (SAS Inc., Cary, NC, USA); p < 0.05 
was regarded as statistically significant.
Results
Clinical characteristics of the study population by thyroid cyst status. Clinical characteristics of 
the study population by thyroid cyst status are shown in Table 1. The proportion of men among participants with 
thyroid cysts was significantly lower than the proportion among participants without thyroid cysts. Participants 
with thyroid cysts were significantly older and had significantly higher SBP than those without thyroid cysts.
Association between hypertension and thyroid cyst status among all participants. Table  2 
shows the ORs for hypertension in relation to the presence of thyroid cysts among all participants. The p value 
for Model 1 was greater than 0.05, indicating no significant difference in hypertension between participants with 
and without thyroid cysts. However, after adjustment for known cardiovascular risk factors (Model 2), there was 
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a statistically significant positive association between hypertension and the presence of thyroid cysts. Model 
3, which also adjusted for thyroid hormone levels, also showed a significant association. The adjusted ORs for 
hypertension with respect to the presence of thyroid cysts were 1.23 (95% CI 0.99–1.53) for Model 1, 1.31 (95% 
CI 1.04–1.65) for Model 2, and 1.32 (95% CI 1.05–1.65) for Model 3.
Association between hypertension and free triiodothyronine (T3) levels. A U-shaped associa-
tion between hypertension and free T3 was observed, even though the analysis did not have sufficient power. 
With the middle quintile of free T3 (Q3) as the reference group, the crude OR for hypertension was 1.24 (95% CI 
0.92–1.68) for the lowest level (Q1) and 1.21 (95% CI 0.89–1.64) for the highest level (Q5) (Table 3).
Association between atherosclerosis and free triiodothyronine (T3) levels. In the crude model, 
an inverse association between atherosclerosis and free T3 was observed. With the lowest quintile of free T3 
(Q1) as the reference group, the crude OR for atherosclerosis was 0.62 (95% CI 0.39–0.99) for Q2, 0.60 (95% CI 
0.37–0.97) for Q3, 0.65 (95% CI 0.41–1.02) for Q4, and 0.54 (95% CI 0.33–0.88) for Q5 (Table 3).
Association between hypertension and thyroid cyst status, stratified by atherosclerosis sta‑
tus. Table 4 shows the association between hypertension and the presence of thyroid cysts after stratifying by 
the presence of atherosclerosis. Among participants without atherosclerosis, the presence of thyroid cysts had a 
statistically significant positive association with hypertension (Model 1: OR 1.34; 95% CI 1.06–1.69; p = 0.015). 
Table 1.  Characteristics of the study population. Values are mean ± standard deviation. TSH thyroid 
stimulating hormone, T3 triiodothyronine, T4 thyroxine, BMI Body mass index, SBP systolic blood pressure, 
DBP diastolic blood pressure, HbA1c hemoglobin A1c, TG triglycerides, HDLc HDL-cholesterol. a Values are 
median [the first quartile, third quartile].b Logarithmic transformation was used for evaluating p.
Thyroid cyst
p(−) (+)
No at risk 1213 588
Men (%) 40.7 29.8 < 0.001
Age (year) 59.7 ± 9.5 62.2 ± 8.3 < 0.001
TSH (μIU/mL) 1.58 [1.10, 2.32]a 1.63 [1.08, 2.43]a 0.819b
Free T3 (pg/mL) 3.2 ± 0.3 3.1 ± 0.3 0.178
Free T4 (ng/dL) 1.2 ± 0.2 1.2 ± 0.2 0.155
BMI (kg/m2) 22.9 ± 3.4 22.6 ± 3.3 0.132
SBP (mmHg) 124 ± 17 126 ± 17 0.005
DBP (mmHg) 73 ± 11 74 ± 10 0.067
Anti-hypertensive medication (%) 28.2 32.8 0.044
Current smoker (%) 14.5 11.4 0.070
Daily drinker (%) 40.6 38.9 0.491
HbA1c (%) 5.6 ± 0.6 5.6 ± 0.6 0.253
TG (mg/dL) 109 ± 87 101 ± 60 0.051
HDLc (mg/dL) 60 ± 15 61 ± 15 0.062
Table 2.  Association between the presence of thyroid cysts and hypertension. Model 1: adjusted for sex 
and age. Model 2: + BMI, smoking status (never, former, current), drinking status (non, often, daily) TG, 
HDLc, HbA1c. Model 3: + TSH, free T3, free T4. Hypertension was defined as SBP ≥ 140 mmHg and/or 
DBP ≥ 90 mmHg and/or taking anti-hypertensive medication. OR odds ratio, CI confidence interval, Ref 
reference, BMI Body mass index, TG triglycerides, HDLc HDL-cholesterol, HbA1c hemoglobin A1c, TSH 




Number of participants 1213 588
Number of case (%) 449 (37.0) 261 (44.4)
Model 1 OR (95% CI) Ref 1.23 (0.99, 1.53) 0.067
Model 2 OR (95% CI) Ref 1.31 (1.04, 1.65) 0.020
Model 3 OR (95% CI) Ref 1.32 (1.05, 1.65) 0.019
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This association remained unchanged after further adjustment for known cardiovascular risk factors and thyroid 
hormone levels (Model 3: adjusted OR 1.49; 95% CI 1.17–1.90; p = 0.001).
Regarding atherosclerosis, Model 1 showed a non-significant inverse tendency (OR 0.60; 95% CI 0.32–1.14; 
p = 0.119). After further adjustment for known cardiovascular risk factors (Model 2), the association was statisti-
cally significant (adjusted OR 0.45; 95% CI 0.22–0.94; p = 0.033). This significant association remained unchanged 
after further adjustment for thyroid hormone levels (adjusted OR 0.49; 95% CI 0.24–0.98; p = 0.043).
The interaction between thyroid cysts and atherosclerosis was associated with hypertension. The adjusted p 
value for the effect of the interaction was p = 0.020 for Model 1, p = 0.002 for Model 2, and p = 0.002 for Model 
3 (Table 4).
For sensitivity analysis, sex-specific associations between hypertension and thyroid cyst status and stratified 
by atherosclerosis status were evaluated in an age-adjusted model. Although power was insufficient due to the 
limited number of participants, essentially the same associations were observed for men and women. Among 
participants without atherosclerosis, positive tendencies were observed in men (n = 581) (adjusted OR 1.44; 
95% CI 0.96–2.16; p = 0.077) and women (n = 1046) (adjusted OR 1.29; 95% CI 0.97–1.72; p = 0.081). Among 
participants with atherosclerosis, inverse tendencies were observed in men (n = 88) (adjusted OR 0.67; 95% CI 
0.27–1.68; p = 0.393) and women (n = 86) (adjusted OR 0.57; 95% CI 0.23–1.41; p = 0.225).
Association between hypertension and thyroid cyst status, stratified by atherosclerosis status 
in participants not taking anti‑hypertensive medications. Among participants without atheroscle-
rosis, there was a statistically significant positive association between the presence of thyroid cysts and systolic 
hypertension, but not with diastolic hypertension. Meanwhile, among participants with atherosclerosis, non-
statistically significant inverse associations were observed for both systolic and diastolic hypertension (Table 5).
Table 3.  Association between hypertension, atherosclerosis and free triiodothyronine (T3) levels. Quintile 
values of free triiodothyronine (T3) for men and women are < 3.1 pg/mL and < 2.9 pg/mL for Q1, 3.1 pg/
mL and 2.9–3.0 pg/mL for Q2, 3.2–3.3 pg/mL and 3.1 pg/mL for Q3, 3.4–3.5 pg/mL and 3.2–3.3 pg/mL 
for Q4, and 3.6 pg/mL ≤ and 3.4 pg/mL ≤ for Q5. Hypertension was defined as SBP ≥ 140 mmHg and/or 
DBP ≥ 90 mmHg and/or taking anti-hypertensive medication. Atherosclerosis was defined as CIMT ≥ 1.1 mm. 
OR odds ratio, CI confidence interval, Ref reference, SBP systolic blood pressure, DBP diastolic blood pressure, 
CIMT carotid intima-media thickness.OR odds ratio, CI confidence interval, Ref reference, SBP systolic blood 
pressure, DBP diastolic blood pressure, CIMT carotid intima-media thickness.
Free triiodothyronine (T3) levels
pQ 1 (low) Q2 Q3 Q4 Q5 (high)
Number of participants 376 350 348 381 346
Hypertension
Number of case (%) 159 (42.3) 130 (37.1) 129 (37.1) 148 (38.8) 144 (41.6)
Crude model OR (95% CI) 1.24 (0.92, 1.68) 1.00 (0.74, 1.36) Ref 1.08 (0.80, 1.46) 1.21 (0.89, 1.64) 0.985
Atherosclerosis
Number of case (%) 51 (13.6) 31 (8.9) 30 (8.6) 35 (9.2) 27 (7.8)
Crude model OR (95% CI) Ref 0.62 (0.39, 0.99) 0.60 (0.37, 0.97) 0.65 (0.41, 1.02) 0.54 (0.33, 0.88) 0.021
Table 4.  Association between the presence of thyroid cysts and hypertension by the existence of 
atherosclerosis. Model 1: adjusted for sex and age. Model 2: + BMI, smoking status (never, former, current), 
drinking status (non, often, daily) TG, HDLc, HbA1c. Model 3: + TSH, free T3, free T4. Hypertension 
was defined as SBP ≥ 140 mmHg and/or DBP ≥ 90 mmHg and/or taking anti-hypertensive medication. 
Atherosclerosis was defined atherosclerosis as CIMT ≥ 1.1 mm. OR odds ratio, CI confidence interval, Ref 
reference, BMI Body mass index, TG triglycerides, HDLc HDL-cholesterol, HbA1c hemoglobin A1c, TSH 
thyroid stimulating hormone, T3 triiodothyronine, T4 thyroxine, SBP systolic blood pressure, DBP diastolic 
blood pressure, CIMT carotid intima-media thickness.





p(−) (+) (−) (+)
Number of participants 1109 518 104 70
Number of case (%) 388 (35.0) 229 (44.2) 61 (58.7) 32 (45.7)
Model 1 OR (95% CI) Ref 1.34 (1.06, 1.69) 0.015 Ref 0.60 (0.32, 1.14) 0.119 0.020
Model 2 OR (95% CI) Ref 1.49 (1.16, 1.90) 0.002 Ref 0.45 (0.22, 0.94) 0.033 0.002
Model 3 OR (95% CI) Ref 1.49 (1.17, 1.90) 0.001 Ref 0.49 (0.24, 0.98) 0.043 0.002
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Discussion
The major finding of our present study is that the presence of atherosclerosis could affect the association between 
the presence of thyroid cysts and hypertension in the general population.
Previously, our study with 1432 euthyroid Japanese individuals revealed a significant inverse association 
between TPO-Abs and thyroid  cysts1. Since TPO-Ab is a known autoimmune antibody that causes autoimmune 
thyroiditis, absence of thyroid cysts among euthyroid individuals might indicate the presence of latent thyroid 
damage. TPO-Ab (+) status is associated with subclinical hypothyroidism and hypertension, but not with sub-
clinical hypothyroidism without  hypertension2. Furthermore, the normal range of TPO-Ab titers is associated 
with atherosclerosis among euthyroid  participants6. Atherosclerosis and hypertension are known to be closely 
 connected9. Therefore, even in individuals normal thyroid function, there could be an unknown connection 
among the presence of thyroid cysts, hypertension, and atherosclerosis.
In the present study, we found further evidence that the presence of thyroid cysts is positively associated 
with hypertension in participants without atherosclerosis and inversely associated with hypertension in those 
with atherosclerosis.
Figure 1 shows the association between hypertension, atherosclerosis, and thyroid function.
Thyroglobulin is a crucial factor in the synthesis of T3 and  T410. Thyroglobulin is abundant in cyst  fluid11. 
Therefore, thyroid cysts might have a beneficial influence on synthesis thyroid hormones.
School age is an important period of physical growth. Lower thyroid function, as in congenital hypothy-
roidism, is known to be associated with slow growth. The number of thyroid cysts was previously shown to be 
associated with more growth in school-age  children12. This finding supports our hypothesis that the presence 
of thyroid cysts indicates a higher capacity for synthesizing and transporting thyroid hormones (T3 and T4).
In addition, our previous study found that subclinical hypothyroidism is positively associated with hyperten-
sion among participants without thyroid cysts but not among participants with thyroid  cysts2. Since hypothyroid-
ism is reported to be associated with  hypertension13, the presence of thyroid cyst might have a beneficial effect 
on the activation of thyroid hormones.
However, in this study, independent from known cardiovascular risk factors, thyroid hormones (free T3 
and free T4), and TSH, the presence of thyroid cysts was significantly positively associated with hypertension 
(Table 2). Therefore, serum concentrations of thyroid hormones and TSH are not efficient tools for evaluating 
the function of thyroid cysts.
Our study population included adults aged 40–74 years. We found that participants with thyroid cysts were 
significantly older than those without thyroid cysts (Table 1). A previous study reported that decreased thyroid 
function might lead to extended  longevity14. Therefore, the aging process might decrease the demand for thyroid 
hormone activity, which results in relatively higher thyroid hormone activity in elderly participants with the 
same thyroid hormone levels as younger participants. The following equation could be established: thyroid func-
tion = actual thyroid hormone level/level of thyroid hormone demand. Participants with comparatively higher 
thyroid hormone activity (thyroid function) might have formed thyroid cysts to store abundant thyroglobulin. 
In this study, no significant differences in TSH, free T3, or free T4 levels were observed between patients with 
Table 5.  Association between the presence of thyroid cysts and hypertension by the existence of 
atherosclerosis in participants without taking anti-hypertensive medication. Model 1: adjusted for sex and 
age. Model 2: + BMI, smoking status (never, former, current), drinking status (non, often, daily) TG, HDLc, 
HbA1c. Model 3: + TSH, free T3, free T4. Systolic hypertension was defined as SBP ≥ 140 mmHg while diastolic 
hypertension was defined as DBP ≥ 90 mmHg. Atherosclerosis was defined atherosclerosis as CIMT ≥ 1.1 mm. 
OR odds ratio, CI confidence interval, Ref reference, BMI Body mass index, TG triglycerides, HDLc HDL-
cholesterol, HbA1c hemoglobin A1c, TSH thyroid stimulating hormone, T3 triiodothyronine, T4 thyroxine, 
SBP systolic blood pressure, DBP diastolic blood pressure, CIMT carotid intima-media thickness.





p(−) (+) (−) (+)
Systolic hypertension
Number of participants 812 349 59 46
Number of case (%) 83 (10.2) 57 (16.3) 14 (23.7) 8 (17.4)
Model 1 OR (95% CI) Ref 1.61 (1.10, 2.36) 0.014 Ref 0.65 (0.24, 1.73) 0.385 0.109
Model 2 OR (95% CI) Ref 1.70 (1.15, 2.52) 0.008 Ref 0.46 (0.14, 1.54) 0.207 0.0497
Model 3 OR (95% CI) Ref 1.71 (1.15, 2.53) 0.008 Ref 0.36 (0.10, 1.37) 0.135 0.044
Diastolic hypertension
Number of participants 812 349 59 46
Number of case (%) 46 (5.7) 20 (5.7) 5 (8.5) 3 (6.5)
Model 1 OR (95% CI) Ref 1.07 (0.61, 1.86) 0.825 Ref 0.88 (0.19, 4.08) 0.874 0.711
Model 2 OR (95% CI) Ref 1.11 (0.63, 1.96) 0.712 Ref 0.55 (0.09, 3.28) 0.509 0.450
Model 3 OR (95% CI) Ref 1.13 (0.64, 1.99) 0.683 Ref 0.58 (0.09, 3.96) 0.577 0.397
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and without thyroid cysts (Table 1). Although evaluation of thyroid function without information on the level 
of demand is not accurate, serum concentrations of free T3 could indicate thyroid function to same extent.
Since hyperthyroidism and hypothyroidism can lead to  hypertension4, we found a U-shaped association 
between free T3 levels and hypertension in the crude model (Table 3; Fig. 1c) despite insufficient power.
Since subclinical hypothyroidism is positively associated with hypertension among participants without 
thyroid cysts but not among participants with thyroid  cysts2, the presence of thyroid cysts might increase thy-
roid function in participants with lower thyroid hormone activity, partly by decreasing the demands for thyroid 
hormones, resulting in a lower risk of hypertension. As shown in Fig. 1b, decreased demands for thyroid hor-
mones associated with thyroid cysts increase thyroid function and shift the axis of thyroid function to the right. 
This right shift reduces the risk of hypertension among participants with comparative lower thyroid hormone 
activity (Fig. 1α) while increasing the risk of hypertension among participants with comparative higher thyroid 
hormone activity (Fig. 1β).
Furthermore, although both hyperthyroidism and hypothyroidism affect the cardiovascular system, hypothy-
roidism is known to be associated with the progression of  atherosclerosis15. In the present study, the crude model 
revealed an inverse association between free T3 and atherosclerosis (Table 3; Fig. 1a). Since the prevalence of 
atherosclerosis is higher among participants with lower thyroid hormone activity (Fig. 1A) than those with higher 
thyroid hormone activity (Fig. 1B), the analysis of participants with atherosclerosis emphasizes the influence of 
lower thyroid hormone activity. Participants with thyroid cysts had higher thyroid function due to a reduced 
demand for thyroid hormones (Fig. 1b). Among participants with thyroid cysts, the risk of hypertension was 
lower among those with atherosclerosis (Table 4; Fig. 1α) whereas the risk of hypertension was higher for those 
without atherosclerosis (Table 4; Fig. 1β).
Figure 2 shows the potential mechanisms for the present results.
Decreased demand for thyroid hormones associated with the process of  aging14 might lead to the formation 
of thyroid cysts that pool  thyroglobulin11 (Table 1; Fig. 2a). Even though participants with and without thyroid 
hormone had similar serum levels of thyroid hormones, participants with thyroid cysts might have higher 
levels of thyroid hormone activity because of the influence of age-related reductions in the demand for thyroid 
hormone (Table 1; Fig. 2b).
Hyperthyroidism is a common cause of isolated systolic  hypertension16. The presence of thyroid cysts was 
shown to be positively associated with systolic hypertension but not with diastolic  hypertension3. These studies 
also support our hypothesis that participants with thyroid cysts could have higher thyroid hormone activity 
than participants without thyroid cysts. In this study, we found a significant positive association between thyroid 
cysts and hypertension (Table 2; Figs. 1b, 2c), possibly indicating that participants with thyroid cysts have higher 
thyroid hormone activity than participants without thyroid cysts.
Since hypothyroidism is known to be associated with the progression of  atherosclerosis15, the influence of 
lower thyroid hormone activity in participants with atherosclerosis was stronger than in participants without 
atherosclerosis. Therefore, in our present study, we found significant inverse associations between the presence of 
thyroid cysts and hypertension in participants with atherosclerosis (Table 4; Figs. 1α, 2d). Atherosclerosis could 
enhance the beneficial effect of preventing hypothyroidism that thyroid cysts might possess.
Figure 1.  Association between hypertension, atherosclerosis and thyroid function (This figure was created by 
using Microsoft PowerPoint 2016; https:// www. micro soft. com/ ja- jp/ micro soft- 365/ power point).
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Further analyses performed among participants with atherosclerosis who were not taking antihypertensive 
medications showed thyroid cysts have an inverse non-statistically significant association with both systolic and 
diastolic hypertension (Table 5; Fig. 2e,f). Further investigation with a larger study population is necessary. How-
ever, the present study suggests that the presence of thyroid cysts could have a beneficial influence on preventing 
both systolic and diastolic hypertension among participant with atherosclerosis by supporting thyroid function.
However, we also observed a significant positive association between hypertension and the presence of thyroid 
cysts in participants without atherosclerosis (Table 4; Figs. 1β, 2g). T3 plays an important role in reducing sys-
temic vascular  resistance17,18, which lowers diastolic blood pressure. However, T3 is also reported to enhance the 
force of myocardial  contractions19, which elevates systolic blood pressure. Therefore, increased T3 activity could 
be associated with systolic hypertension but not with diastolic hypertension. Indeed, a previous study reported 
hyperthyroidism as a common cause of isolated systolic  hypertension16. The presence of thyroid cysts might, to 
a certain extent, indicate that the thyroid can produce a sufficient amount of thyroid hormones. Therefore, the 
production of thyroid hormones is easily accelerated in participants with thyroid cysts. In our present study, sig-
nificant positive associations between systolic hypertension and thyroid cysts were observed among participants 
without atherosclerosis who were not taking antihypertensive medications (Table 5; Fig. 2h). However, there were 
no significant associations between diastolic hypertension and the presence of thyroid cysts (Table 5; Fig. 2i).
Unlike the results of a previous general population study, present single population study pointed out com-
pletely different associations between participants with and without thyroid cysts. This study provided novel 
evidence that the same factor has both favorable and unfavorable characteristics for health maintenance. Moreo-
ver, the clinical status of the participants might determine these characteristics, as in our previous  study20,21. 
Therefore, this study provided new insights into mechanisms related to thyroid hormones.
The clinical perspective of our present study is that even though thyroid cysts are generally regarded to be 
less clinically important, data on their presence and atherosclerosis could be helpful in evaluating health risks 
(e.g., hypertension) in daily clinical practice. Furthermore, this study also revealed the necessity of evaluating 
an individual’s thyroid hormone demands when evaluating individual thyroid function.
Our present study has certain limitations. First, we evaluated the presence or absence of thyroid cysts, but 
the number and size of the cysts might also be important factors. Although cyst fluid was rich in thyroglobulin, 
the presence of anti-thyroglobulin antibodies reduces thyroglobulin levels dramatically. It might act as a strong 
confounding factor in our present analysis. However, because of the limited volume of each blood sample, we 
were not able to evaluate the influence of anti-thyroglobulin antibodies. Therefore, it is of great importance 
to conduct further investigations focusing on the number and size of cysts, as well as the presence of anti-
thyroglobulin antibodies. Although the metabolism of thyroid hormones in participants with thyroid cysts who 
do not have atherosclerosis might be accelerated, we could not evaluate this relationship. Finally, as this study is 
cross-sectional by nature, no causal relationship could be established.
Figure 2.  Potential mechanisms for the present results. Association shown in red (a–i) were observed in the 
present study. TSH thyroid stimulating hormone, free T3 free triiodothyronine, Cyst thyroid cysts, SHT systolic 
hypertension, DHT diastolic hypertension. *1: Observed among participants without taking anti-hypertensive 
medication. #: The statistical power could not reach significant level. (This figure was created by using Microsoft 
PowerPoint 2016; https:// www. micro soft. com/ ja- jp/ micro soft- 365/ power point).
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Conclusion
In conclusion, in the general population, the presence of thyroid cysts was positively associated with hypertension 
in participants without atherosclerosis and inversely associated with hypertension in those with atherosclerosis. 
Although it is necessary to carry out further investigation, our present findings could sufficiently inform the 
development of a method to assess the risk of hypertension for the general population.
Data availability
We cannot publicly provide individual data due to participant privacy, according to ethical guidelines in Japan. 
Additionally, the informed consent was obtained does not include a provision for publicity sharing data. Qualify-
ing researchers may apply to access a minimal dataset by contacting Prof Naomi Hayashida, Principal Investi-
gator, Division of Promotion of Collaborative Research on Radiation and Environment Health Effects, Atomic 
Bomb Disease Institute, Nagasaki University, Nagasaki, Japan at naomin@nagasaki-u.ac.jp. Or, please contact 
the office of data management at ritouken@vc.fctv-net.jp. Information for where data request is also available at 
https:// www. genken. nagas aki-u. ac. jp/ dscr/ messa ge/ and http:// www. med. nagas aki-u. ac. jp/ cm/.
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